Cover Image
市場調查報告書

美國的內視鏡取血管手術(EVH)用設備市場

US Market Report for Endoscopic Vessel Harvesting Devices 2018 - MedCore

出版商 iData Research Inc. 商品編碼 590195
出版日期 內容資訊 英文 379 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的內視鏡取血管手術(EVH)用設備市場 US Market Report for Endoscopic Vessel Harvesting Devices 2018 - MedCore
出版日期: 2017年11月01日 內容資訊: 英文 379 Pages
簡介

本報告提供美國的內視鏡取血管手術(EVH)用設備市場調查,總括性彙整市場及疾病概要,各種產品的評估,臨床實驗·回收狀況,市場促進·阻礙因素分析,企業的市場佔有率等資訊。

目錄

圖表

摘要整理

美國的心血管手術及心臟瓣膜市場

競爭分析

市場趨勢

市場發展

治療數量

調查對象醫療編碼

調查對象市場

更新資訊

修訂履歷

第1章 調查手法

第2章 疾病概要

  • 基本結構
    • 冠狀動脈疾病
    • 心肌梗塞
    • 心絞痛
    • 心臟瓣膜疾病
    • 鬱血性心衰竭

第3章 產品系列

  • 產品系列
    • 生物學心臟瓣膜
    • 機械瓣膜
    • 瓣環成形術術用設備
    • 經導管主動脈瓣置換術(TAVR)用設備
    • 經導管二尖瓣瓣膜修復術用設備
    • 體外循環輔助下冠狀動脈繞道手術(ONCAB)用設備
    • 非體外循環冠狀動脈繞道手術(OPCAB)用設備
    • 內視鏡取血管手術(EVH)用設備
    • 血管吻合補助設備
    • 心肌內血液循環重組術用設備
    • 輔助人工心臟
    • 主動脈內球囊泵(IABP)用設備
    • 遠隔血液動態監測設備
    • 卵圓孔未閉合(PFO) 用設備
    • 心室中隔缺損症(VSD)·心房中隔缺損(ASD)用設備
    • 左心房封閉用設備
    • 體外式薄膜型人工肺
  • FDA的回收
    • MAQUET
    • Medtronic
    • HeartWare Inc
  • 臨床實驗
    • Medtronic
    • St. Jude Medical
    • Abiomed
    • Heartware Inc

第4章 內視鏡取血管手術(EVH)用設備市場

  • 簡介
  • 市場分析與預測
  • 市場促進·阻礙因素
    • 推動市場要素
    • 市場阻礙因素
  • 市場佔有率分析

簡稱一覽

附錄:企業的新聞稿

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USCS18_MC_EVH

Coronary artery bypass graft (CABG) procedures involve bypassing a weakened or damaged artery with another vessel to bypass the blocked and diseased portion of the coronary artery and maintain blood flow. The vessels most often used are the saphenous vein in the leg, the radial artery in the arm or the mammary artery from the chest wall. Vessel harvesting may be performed with an open incision or endoscopically. Endoscopy allows for a small, minimally invasive incision to be made rather than the much larger incision required for open harvesting. Endoscopic vessel harvesting (EVH) devices have become the standard of care for vessel harvesting during CABG procedures performed in the United States. The vessels obtained using EVH devices provide excellent conduit quality and hemostasis results. Furthermore, EVH procedures reduce patient discomfort and scarring as well as recovery time for the patient. This acts to improve patient outcomes and increase overall satisfaction.

In an EVH procedure, the EVH device is inserted into the patient via an incision approximately one inch long either in the patient's leg, arm or chest, depending on the vessel being procured. When the vessel is being removed from the patient's leg or arm, the non-dominant limb is generally used for decreasing patient discomfort after the procedure. Using endoscopic techniques, any tissue that is connected to the vessel is cut away and the vessel is removed through a secondary incision.

As it lessens patient discomfort and recovery times, EVH procedures have become the preferred method of obtaining vessels for CABG procedures. However, some vessels are still obtained using open harvesting methods at the discretion of the physician.

TABLE OF CONTENTS I

LIST OF FIGURES XII

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 11

PROCEDURE NUMBERS 12

PROCEDURE CODES INVESTIGATED 16

MARKETS INCLUDED 17

KEY REPORT UPDATES 19

VERSION HISTORY 20

RESEARCH METHODOLOGY 21

    • Step 1: Project Initiation & Team Selection 21
    • Step 2: Prepare Data Systems and Perform Secondary Research 24
    • Step 3: Preparation for Interviews & Questionnaire Design 26
    • Step 4: Performing Primary Research 27
    • Step 5: Research Analysis: Establishing Baseline Estimates 29
    • Step 6: Market Forecasts and Analysis 30
    • Step 7: Identify Strategic Opportunities 32
    • Step 8: Final Review and Market Release 33
    • Step 9: Customer Feedback and Market Monitoring 34

DISEASE OVERVIEW 35

  • 2.1 BASIC ANATOMY 35
    • 2.1.11 Coronary Artery Disease 37
    • 2.1.12 Myocardial Infarction 37
    • 2.1.13 Angina Pectoris 38
    • 2.1.14 Heart Valve Disease 39
    • 2.1.15 Congestive Heart Failure 39

PRODUCT PORTFOLIO 41

    • 3.1.1 Tissue Heart Valves 41
    • 3.1.2 Mechanical Tissue Heart Valves 43
    • 3.1.3 Annuloplasty Repair Devices 45
    • 3.1.4 Transcatheter Aortic Valve Replacement Devices 47
    • 3.1.5 Transcatheter Mitral Valve Repair Devices 49
    • 3.1.6 On-Pump Coronary Artery Bypass Devices 50
    • 3.1.7 Off-Pump Coronary Artery Bypass Devices 52
    • 3.1.8 Endoscopic Vessel Harvesting Devices 53
    • 3.1.9 Anastomosis Assist Devices 54
    • 3.1.10 Transmyocardial Revascularization Devices 55
    • 3.1.11 Ventricular Assist Devices 56
    • 3.1.12 Intra-Aortic Balloon Pump Device 57
    • 3.1.13 Temporary Artificial Heart Replacement Device 58
    • 3.1.14 Remote Hemodynamic Monitoring System Devices 59
    • 3.1.15 Patent Foramen Ovale Devices 59
    • 3.1.16 Atrial & Ventricular Septal Defect Device 61
    • 3.1.17 Left Atrial Appendage Closure Device 62
    • 3.1.18 Extracorporeal Membrane Oxygenation Machine 63
  • 3.2 FDA RECALLS 64
    • 3.2.1 MAQUET 64
    • 3.2.2 Medtronic 66
    • 3.2.3 HeartWare Inc 67
  • 3.3 CLINICAL TRIALS 68
    • 3.3.1 Medtronic 68
    • 3.3.2 St. Jude Medical 70
    • 3.3.3 Abiomed 75
    • 3.3.4 Heartware Inc 76

ENDOSCOPIC VESSEL HARVESTING DEVICE MARKET 78

  • 4.1 INTRODUCTION 78
  • 4.2 MARKET ANALYSIS AND FORECAST 80
  • 4.3 DRIVERS AND LIMITERS 82
    • 4.3.1 Market Drivers 82
    • 4.3.2 Market Limiters 82
  • 4.4 COMPETITIVE MARKET SHARE ANALYSIS 84

ABBREVIATIONS 87

APPENDIX: COMPANY PRESS RELEASES 90

LIST OF CHARTS

  • Chart 1 1: Cardiac Surgery and Heart Valve Devices Market by Segment, U.S., 2014 - 2024 3
  • Chart 1 2: Cardiac Surgery and Heart Valve Devices Market Overview, U.S., 2017 & 2024 3
  • Chart 4 1: Endoscopic Vessel Harvesting Device Market, U.S., 2014 - 2024 81
  • Chart 4 2: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2017 86

LIST OF FIGURES

  • Figure 1 1: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (1 of 4) 4
  • Figure 1 2: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (2 of 4) 5
  • Figure 1 3: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (3 of 4) 5
  • Figure 1 4: Cardiac Surgery and Heart Valve Devices Market Share Ranking by Segment, U.S., 2017 (4 of 4) 5
  • Figure 1 5: Companies Researched in this Report, U.S., 2017 6
  • Figure 1 6: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (1 of 4) 7
  • Figure 1 7: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (2 of 4) 8
  • Figure 1 8: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (3 of 4) 9
  • Figure 1 9: Factors Impacting the Cardiac Surgery and Heart Valve Devices Market by Segment, U.S. (4 of 4) 10
  • Figure 1 10: Recent Events in the Cardiac Surgery and Heart Valve Devices Market, U.S., 2015 - 2017 11
  • Figure 1 11: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (1 of 4) 12
  • Figure 1 12: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (2 of 4) 13
  • Figure 1 13: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (3 of 4) 14
  • Figure 1 14: Cardiac Surgery and Heart Valve Devices Procedures Covered, U.S., 2017 (4 of 4) 15
  • Figure 1 15: Procedure Codes Investigated, U.S., 2017 16
  • Figure 1 16: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (1 of 2) 17
  • Figure 1 17: Cardiac Surgery and Heart Valve Devices Markets Covered, U.S., 2017 (2 of 2) 18
  • Figure 1 18: Key Report Updates (1 of 2) 19
  • Figure 1 19: Key Report Updates (2 of 2) 20
  • Figure 1 20: Version History 20
  • Figure 3 1: Tissue Heart Valves by Company 42
  • Figure 3 2: Mechanical Tissue Heart Valves by Company 44
  • Figure 3 3: Annuloplasty Repair Devices by Company 46
  • Figure 3 4: Transcatheter Heart Valve Replacement Devices by Company 48
  • Figure 3 5: Transcatheter Mitral Valve Repair Devices by Company 49
  • Figure 3 6: On-Pump Coronary Artery Bypass Devices by Company 51
  • Figure 3 7: Off-Pump Coronary Artery Bypass Devices by Company 52
  • Figure 3 8: Endoscopic Vessel Harvesting Devices by Company 53
  • Figure 3 9: Anastomosis Assist Devices by Company 54
  • Figure 3 10: Transmyocardial Revascularization Devices by Company 55
  • Figure 3 11: Ventricular Assist Devices by Company 56
  • Figure 3 12: Intra-Aortic Balloon Devices by Company 57
  • Figure 3 13: Temporary Artificial Heart Replacement Devices by Company 58
  • Figure 3 14: Remote Hemodynamic Monitoring System Devices by Company 59
  • Figure 3 15: Patent Foramen Ovale Devices by Company 60
  • Figure 3 16: Atrial & Ventricular Septal Defect Devices by Company 61
  • Figure 3 17: Left Atrial Appendage Closure Devices by Company 62
  • Figure 3 18: Extracorporeal Membrane Oxygenation Machine by Company 63
  • Figure 3 19: Class 2 Device Recall MAQUET 64
  • Figure 3 20: Class 2 Device Recall MAQUET 64
  • Figure 3 21: Class 2 Device Recall MAQUET 65
  • Figure 3 22: Class 1 Device Recall Medtronic 66
  • Figure 3 23: Class 1 Device Recall Heartware Inc 67
  • Figure 3 24: The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study 68
  • Figure 3 25: Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance 68
  • Figure 3 26: Medtronic CoreValve Evolut R U.S. Clinical Study 69
  • Figure 3 27: Medtronic Transcatheter Aortic Valve Replacement in Low Risk Patients 69
  • Figure 3 28: AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption 70
  • Figure 3 29: AMPLATZER Duct Occluder II Additional Sizes (ADO II AS) 70
  • Figure 3 30: HeartMate 3 CE Mark Study Long Term Follow-up (HM3 CE LTFU) 71
  • Figure 3 31: Trifecta™ GT Post Market Clinical Follow-up 71
  • Figure 3 32: AMPLATZER™ LAA Occluder Post Approval Study (PAS) 72
  • Figure 3 33: AMPLATZER™ Cardiac Plug Observational Post-Approval Study (ACP PAS China) 72
  • Figure 3 34: MOMENTUM 3 Continued Access Protocol (MOMENTUM 3 CAP) 73
  • Figure 3 35: AMPLATZER™ Amulet™ LAA Occluder Trial (Amulet IDE) 73
  • Figure 3 36: Prevention of Non-Surgical Bleeding by Management of HeartMate II 74
  • Figure 3 37: Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction (DTU) 75
  • Figure 3 38: Protected PCI Study 75
  • Figure 3 39: Assessment of the WATCHMAN™ Device 76
  • Figure 3 40: Watchman FLX Left Atrial Appendage Closure Device Post Approval Study 76
  • Figure 3 41: Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology 77
  • Figure 4 1: Endoscopic Vessel Harvesting Device Market, U.S., 2014 - 2024 80
  • Figure 4 2: Drivers and Limiters, Endoscopic Vessel Harvesting Device Market, U.S., 2017 83
  • Figure 4 3: Leading Competitors, Endoscopic Vessel Harvesting Device Market, U.S., 2017 85
  • Figure 6 1: Press Release Summary 90
Back to Top